Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Eslicarbazepine acetate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eslicarbazepine 800mg tablets
0408010AIAAAAAA
|
Eslicarbazepine acetate | Eslicarbazepine acetate | Central Nervous System | 5,983 |
|
Eslicarbazepine 200mg tablets
0408010AIAAABAB
|
Eslicarbazepine acetate | Eslicarbazepine acetate | Central Nervous System | 4,802 |
|
Zebinix 800mg tablets
0408010AIBBAAAA
|
Zebinix | Eslicarbazepine acetate | Central Nervous System | 704 |
|
Zebinix 200mg tablets
0408010AIBBABAB
|
Zebinix | Eslicarbazepine acetate | Central Nervous System | 346 |
|
Eslicarbazepine 50mg/1ml oral suspension sugar free
0408010AIAAACAC
|
Eslicarbazepine acetate | Eslicarbazepine acetate | Central Nervous System | 225 |
|
Zebinix 50mg/1ml oral suspension
0408010AIBBACAC
|
Zebinix | Eslicarbazepine acetate | Central Nervous System | 24 |
|
Arupsan 800mg tablets
0408010AIBCABAA
|
Arupsan | Eslicarbazepine acetate | Central Nervous System | 6 |
|
Arupsan 200mg tablets
0408010AIBCAAAB
|
Arupsan | Eslicarbazepine acetate | Central Nervous System | 4 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.